Article
The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children.
European journal of clinical pharmacology - 1 Jan 2000
Zielińska E, Niewiarowski W, Bodalski J
Abstract excerpt
OBJECTIVE: The evaluation of the importance of the genetically determined acetylation defect for the development of adverse reactions to co-trimoxazole in children. METHODS: The study comprised 48 children aged 3 months to 3 years, who were being treated for interstitial pneumonia with co-trimoxazole. During the treatment, daily clinical examinations and biochemical tests to monitor the functions in various...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
